Join to View Full Profile
700 W Ironwood DrSte 130Coeur d'Alene, ID 83814
Phone+1 509-228-1000
Fax+1 509-252-9300
Dr. MacDonald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. O. Kenneth Macdonald is a radiation oncologist based in Spokane, WA, with a focus on lung cancer and stereotactic body radiotherapy. He completed his residency in Radiation Oncology at the University of Utah Health Sciences Center and holds an MD from McGovern Medical School at UTHealth. Dr. Macdonald currently serves as a physician at Cancer Care Northwest and previously was the Medical Director at both Therapeutic Radiologists Inc PA and Saint Luke's East Hospital. His research includes multiple publications in notable journals, with a significant focus on stereotactic body radiotherapy. He received the CMS Meaningful Use Stage 1 Certification from ARIA Oncology Information System in 2015.
Education & Training
University of Utah HealthResidency, Radiation Oncology, 2003 - 2007
Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2002 - 2003
McGovern Medical School at UTHealthClass of 2002
Certifications & Licensure
UT State Medical License 2003 - 2028
ID State Medical License 2021 - 2027
MO State Medical License 2010 - 2027
WA State Medical License 2021 - 2027
KS State Medical License 2010 - 2022
WI State Medical License 2007 - 2011
MN State Medical License 2007 - 2010
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2015
Publications & Presentations
PubMed
- 5 citationsMulticenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the P...Kevin C Flanagan, Jon Earls, Jeffrey Hiken, Rachel L Wellinghoff, Michelle M Ponder
Journal for Immunotherapy of Cancer. 2024-11-03 - 6 citationsMultidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L Wellinghoff
Journal of Cancer Research and Clinical Oncology. 2023-11-01 - 31 citationsRadiotherapy and Male Breast Cancer: A Population-based Registry Analysis.Nicholas A. Madden, Orlan K. Macdonald, Jason A. Call, David A. Schomas, Christopher M. Lee
American Journal of Clinical Oncology. 2016-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
